Previous Meetings

IKMG - INTERNATIONAL KIDNEY & MONOCLONAL GAMMOPATHY RESEARCH GROUP - FIFTH INTERNATIONAL MEETING
May 18, 19 2023
Milan, Italy
Program

IKMG Business Meeting at the International Society of Amyloidosis
March 3rd, 2020
Tarragona, Spain

International Kidney and Monoclonal Gammopathy Research Group:
Fourth International Meeting
Montreal, Canada
May 23-34, 2019

International Kidney and Monoclonal Gammopathy Research Group:
Third International Meeting
New Orleans, Louisiana
April 27-28, 2017

PROGRAM
Thursday, April 27, 2017
7:00 am – 8:00 am: Registration open
7:00 am – 8:30 am: Breakfast and Exhibits
8:15 am – 10:15 am: GENERAL THEMES; Robert Kyle, Vecihi Batuman: Chairs

  1. Opening Remarks: Robert Kyle

  2. The expanding spectrum of monoclonal gammopathies and MGRS: Nelson Leung

  3. Kidney injury from paraproteins-the role of inflammatory pathways: Vecihi Batuman

  4. Newer treatments of multiple myeloma—effects on renal involvement: Brendan Weiss

10:15 am – 10:30 am: BREAK      
10:30 am – 12:30 pm: BASIC –EXPERIMENTAL; Marina Ramirez-Alvarado, Guillermo Herrera: Chairs

  1. Monoclonal immunoglobulin deposition disease: Christophe Sirac

  2. Cast nephropathy—from bench to bedside: Paul Sanders

  3. Newer Insights into amyloidogenesis—Guillermo Herrera

  4. LC associated interstitial nephritis—Maria Picken

12:30 pm – 2:00 pm: Lunch on own
2:00 pm – 3:30 pm: AIg AMYLOIDOSIS; Arnaud Jaccard, Robert Kyle, Chairs

  1. Update on the treatment of AL amyloidosis— Ashutosh Wechalekar

  2. Non chemotherapy based treatment—Suzanne Lentzsch

  3. Effects of cytogenetics on AL amyloidosis – Angela Dispenzieri

3:30 pm – 5:00 pm: PATHOLOGY; Maria Picken, Samih Nasr: Chairs

  1. State of the art of the techniques for the diagnosis of MGRS- Samih Nasr

  2. Light chain proximal tubulopathy –Vivette D’Agati

  3. C3 glomerulopathy and monoclonal Gammopathy—Virginie Royal

5:00 pm – 5:15 pm: Break
5:15 pm – 6:15 pm: DEBATE: EXTRACORPOREAL REMOVAL OF LIGHT CHAINS FOR MCN- Nelson Leung and Efsthathios Kastritis, Chairs

  1. Pro- view—speaker: Jean Paul Fermand

  2. Con- view—speaker: Paul Cockwell

  3. Rebuttals

6:15 pm – 7:30 pm: Poster viewing, Reception, Exhibits

Friday, April 28, 2017
7:00 am – 8:00 am: Registration open
7:00 am – 8:00 am: Breakfast and Exhibits
8:15 am- 10:15 am: MGRS; Angela Dispenzieri and Chris Venner: Chairs

  1. Novel developments on the pathogenesis and treatment strategy on C3 glomerulopathy—Sophie Chauvet

  2. Renal transplant in MGRS - Julian Gillmore

  3. Response criteria for MIDD – Frank Bridoux

  4. Monoclonal Gammopathy-associated TMA—Véronique Frémeaux-Bacchi

10:15am - 10:30 am: Break
10:30 – 11:30 am: Clones other than plasma cell – Brendan Weiss and Ashutosh Wechalekar, Chairs

  1. Management of Waldenström macroglobulinemia - Prashant Kapoor

  2. Treating CLL in the setting a kidney disease - Tim Call

 11:30 am-12:30 noon: THE FUTURE – Frank Bridoux and Paul Sanders, Chairs

  1. Can we cure amyloidosis: Morie Gertz

  2. Future(istic) strategies to prevent renal disease in monoclonal Gammopathy: Nelson Leung

12:30 pm – 2:00 pm: Lunch on own – Exhibits open
2:00 pm – 4:00 pm: Oral Communications
4:00 pm – 4:15 pm: Closing remarks - Nelson Leung

4:30 pm – 6:30 pm: IKMG Board meeting

International Kidney and Monoclonal Gammopathy Research Group 2nd International Meeting
La Rochelle, France
September 3-4, 2015

Program

Abstract Book

 

Thursday, September 3rd  
8:15 a.m. – 9:15 a.m.
Introduction: Guy Touchard and Nelson Leung
The history of monoclonal gammopathies: Robert A. Kyle
MGRS: an evolving concept: Nelson Leung
Classification of renal disorders in monoclonal gammopathies: Guy Touchard 
The kidney biopsy in MGRS: recent advances in pathology: Samih Nasr  

Coffee break  

9:30 a.m. – 12:30 p.m. Proximal Tubule in Monoclonal Gammopathy: From the microscope to the Lab
Light chain tubulopathy with crystals – Vivette D’Agati
LC proximal tubulopathy without crystals: Guillermo Herrera
LC-induced interstitial nephritis: Maria Picken 
Inflammatory pathways involved in proximal tubular injury:  Veichi Batuman
Panel discussion

2:00 p.m. – 3:00 p.m. Updateon monoclonal protein detection/measurement
New free light chain assays: Ashu Wechalekar 
Mass spectrometry: David Murray  

3:00 p.m. – 4:15 p.m. New Renal response and emerging therapies in AL amyloidosis
Assessing renal response in AL amyloidosis: Giampaolo Merlini
Anti-SAP therapy – Julian Gillmore
Anti-fibril therapy – Brendan Weiss  

Coffee break  

4:30 p.m. –  6:00 p.m. Update on the management of myeloma cast nephropathy
Chemotherapeutic options: Dimopoulos group
Free light chain removal: Colin Hutchison? Paul Cockwell?
Response measurement: Heinz Ludwig  
Group discussion  

6:00 p.m. Poster viewing and wine reception   

Friday, September. 4th
8:30 a.m. – 10:30 a.m. Update in pathophysiology: animal models
Cast nephropathy: Paul Sanders
LC Fanconi syndrome: Olivier Devuyst
AL amyloidosis: Guillermo Herrera
Randall-type MIDD: Christophe Sirac  

Coffee break  

10:45 a.m. – 12:00 a.m. C3 glomerulopathy and monoclonal gammopathy
C3 GP and monoclonal gammopathy: the disease spectrum: Frank Bridoux
The complement system in C3GP and monoclonal gammopathy: Véronique Frémeaux- Bacchi  

12:00 – 12:45:  Extrarenal manifestations of monoclonal gammopathy: Jean Paul Fermand  

2:00 p.m. – 4:00 p.m. Oral communications  

4:00 p.m. Closing remarks  

4:30 p.m. IKMG meeting

5:30 p.m. IKMG Board meeting